非肿瘤性泌尿生殖系统疾病经济负担的范围综述
本研究对1990至2020年间发表的关于非肿瘤性泌尿生殖系统疾病(NCGUC)经济成本的文章进行了范围综述。初检获得3298篇文章,最终纳入39篇相关文献,涉及盆腔器官脱垂、间质性膀胱炎、神经源性膀胱、夜尿症、尿路感染、尿石症、尿失禁、良性前列腺增生、膀胱过度活动症和勃起功能障碍等疾病。结论指出,尽管现有数据有限,但证据表明NCGUC的医疗支出占比较大,且许多支出为难以测量的自付和间接成本,可能低估了实际经济负担,需要未来研究全面评估其经济影响。
要点
- NCGUC经济负担证据有限,但现有研究显示医疗支出显著。
- 自付和间接成本难以测量,可能增加实际经济负担。
- 未来需全面研究NCGUC的经济影响。
核心结论
- 现有证据表明非肿瘤性泌尿生殖系统疾病占显著医疗支出,但估算数据有限。
- 许多支出为自付和间接成本,难以测量,可能增加实际费用规模。
- 需要未来研究全面审视非肿瘤性泌尿生殖系统疾病的经济影响。
研究设计与样本
- 范围综述,检索1990至2020年文献,初检获得3298篇文章,最终纳入39篇相关文献。
主要发现
- 纳入的39篇文章涉及盆腔器官脱垂、间质性膀胱炎、神经源性膀胱、夜尿症、尿路感染、尿石症、尿失禁、良性前列腺增生、膀胱过度活动症和勃起功能障碍等疾病的经济成本数据。
局限性
- 估算经济负担的数据有限。
- 许多支出为自付和间接成本,难以测量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide a scoping review of the economic burden of non-cancerous genitourinary conditions (NCGUC). METHODS: A scoping review of the economic costs associated with NCGUC was conducted for literature published between 1990-2020. The articles were screened and relevant articles were selected for review. These articles were abstracted with information pertaining to the costs surrounding NCGUC. A descriptive analysis of the data was conducted. RESULTS: We found 3,298 articles in our scoping review. Of these, we found 39 relevant articles related to pelvic floor dysfunction and pelvic organ prolapse, interstitial cystitis, neurogenic bladder, nocturia, urinary tract infections, urolithiasis, urinary incontinence, benign prostatic hyperplasia, overactive bladder, and erectile dysfunction of which the data was reviewed. CONCLUSION: Although the data in estimating the economic burden is limited, existing evidence demonstrates a significant component of health care spending on NCGUC. Much of the spending is out-of-pocket and indirect costs that are difficult to measure which may increase the magnitude of the costs. There is a need for future research that takes a holistic look at the economic impact of NCGUC.
引用
- Kim MM, Harvey J, Gusev A, et al. A Scoping Review of the Economic Burden of Non-Cancerous Genitourinary Conditions. Urology. 2021. PMID: 34688770. doi:10.1016/j.urology.2021.10.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。